HEADER    TRANSCRIPTION                           07-DEC-09   3KZ3              
TITLE     A STRUCTURE OF A LAMBDA REPRESSOR FRAGMENT MUTANT                     
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: REPRESSOR PROTEIN CI;                                      
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 FRAGMENT: UNP RESIDUES 8-85;                                         
COMPND   5 ENGINEERED: YES;                                                     
COMPND   6 MUTATION: YES                                                        
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: ENTEROBACTERIA PHAGE LAMBDA;                    
SOURCE   3 ORGANISM_COMMON: BACTERIOPHAGE LAMBDA;                               
SOURCE   4 ORGANISM_TAXID: 10710;                                               
SOURCE   5 GENE: CI;                                                            
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   8 EXPRESSION_SYSTEM_STRAIN: BL-21;                                     
SOURCE   9 EXPRESSION_SYSTEM_VECTOR_TYPE: ROSETTA                               
KEYWDS    FIVE HELIX BUNDLE, DNA-BINDING, REPRESSOR, TRANSCRIPTION,             
KEYWDS   2 TRANSCRIPTION REGULATION                                             
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    M.GRUEBELE,F.LIU,Y.GAO                                                
REVDAT   3   13-OCT-21 3KZ3    1       SEQADV                                   
REVDAT   2   07-APR-10 3KZ3    1       JRNL                                     
REVDAT   1   23-FEB-10 3KZ3    0                                                
JRNL        AUTH   F.LIU,Y.G.GAO,M.GRUEBELE                                     
JRNL        TITL   A SURVEY OF LAMBDA REPRESSOR FRAGMENTS FROM TWO-STATE TO     
JRNL        TITL 2 DOWNHILL FOLDING.                                            
JRNL        REF    J.MOL.BIOL.                   V. 397   789 2010              
JRNL        REFN                   ISSN 0022-2836                               
JRNL        PMID   20138892                                                     
JRNL        DOI    10.1016/J.JMB.2010.01.071                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.64 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-97                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.64                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 10.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 93.8                           
REMARK   3   CROSS-VALIDATION METHOD           : FREE R                         
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM                         
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : 0.193                  
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.189                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : NULL                   
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 0.000                  
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : NULL                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 18248                  
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : 0.189                  
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : 0.188                  
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : 0.213                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000                  
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : NULL                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : 17329                  
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 1236                                          
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 0                                             
REMARK   3   SOLVENT ATOMS      : 282                                           
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : NULL                    
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : NULL                    
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL                    
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : NULL                    
REMARK   3   NUMBER OF RESTRAINTS                     : NULL                    
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.007                   
REMARK   3   ANGLE DISTANCES                      (A) : 1.957                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000                   
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.022                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.036                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.043                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : 0.017                   
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : 0.000                   
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.070                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : 0.000                   
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: NULL                                                  
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER                      
REMARK   3   SPECIAL CASE: NULL                                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: ANISOTROPIC SCALING APPLIED BY THE        
REMARK   3  METHOD OF PARKIN, MOEZZI & HOPE                                     
REMARK   4                                                                      
REMARK   4 3KZ3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JAN-10.                  
REMARK 100 THE DEPOSITION ID IS D_1000056627.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 26-SEP-08                          
REMARK 200  TEMPERATURE           (KELVIN) : 173                                
REMARK 200  PH                             : 6.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : SSRL                               
REMARK 200  BEAMLINE                       : BL9-3                              
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.97                               
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : MAR CCD 130 MM                     
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : HKL-2000                           
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 19544                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.640                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 30.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 99.1                               
REMARK 200  DATA REDUNDANCY                : 7.300                              
REMARK 200  R MERGE                    (I) : 0.06700                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : NULL                               
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.64                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.70                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 90.9                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 6.60                               
REMARK 200  R MERGE FOR SHELL          (I) : NULL                               
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO                    
REMARK 200 SOFTWARE USED: AMORE                                                 
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 46.59                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG, PH 6.5, VAPOR DIFFUSION, HANGING    
REMARK 280  DROP, TEMPERATURE 277K                                              
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1                         
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y+1/2,-Z                                             
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000       29.35500            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1, 2, 3                                                 
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 2                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 3                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    ARG A  15   CD  -  NE  -  CZ  ANGL. DEV. =  14.0 DEGREES          
REMARK 500    ARG A  15   NE  -  CZ  -  NH1 ANGL. DEV. =   5.5 DEGREES          
REMARK 500    VAL B  35   CA  -  CB  -  CG2 ANGL. DEV. = -10.7 DEGREES          
REMARK 500    ARG B  81   CD  -  NE  -  CZ  ANGL. DEV. =  11.2 DEGREES          
REMARK 500    ARG B  81   NE  -  CZ  -  NH1 ANGL. DEV. =   3.0 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1LMB   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF WILD TYPE LAMBDA REPRESSOR                              
REMARK 999                                                                      
REMARK 999 SEQUENCE                                                             
REMARK 999 ACCORDING TO THE AUTHORS, THE PROTEIN WAS DERIVED FROM OAS TG'S      
REMARK 999 LAMBDA REPRESSOR PROTEIN EXPRESSION VECTOR WHICH CARRIES THE CHANGE  
REMARK 999 OF THE FIRST N-TERM AND THE LAST C-TERM RESIDUES. THESE TWO CHANGES  
REMARK 999 CAME FROM THE PREPARATION OF THE EXPRESSION SYSTEM, POSSIBLY THE     
REMARK 999 RESTRICTION ENZYME DIGESTION SITE DESIGN WHEN THE DNA SEQUENCE WAS   
REMARK 999 CUT FROM THE WILD-TYPE PROTEIN AND INSERTED INTO THE VECTOR          
DBREF  3KZ3 A    6    83  UNP    P03034   RPC1_LAMBD       8     85             
DBREF  3KZ3 B    6    83  UNP    P03034   RPC1_LAMBD       8     85             
SEQADV 3KZ3 SER A    5  UNP  P03034              SEE REMARK 999                 
SEQADV 3KZ3 TRP A   21  UNP  P03034    TYR    23 ENGINEERED MUTATION            
SEQADV 3KZ3 TYR A   32  UNP  P03034    GLN    34 ENGINEERED MUTATION            
SEQADV 3KZ3 ALA A   45  UNP  P03034    GLY    47 ENGINEERED MUTATION            
SEQADV 3KZ3 ALA A   47  UNP  P03034    GLY    49 ENGINEERED MUTATION            
SEQADV 3KZ3 ARG A   84  UNP  P03034              SEE REMARK 999                 
SEQADV 3KZ3 SER B    5  UNP  P03034              SEE REMARK 999                 
SEQADV 3KZ3 TRP B   21  UNP  P03034    TYR    23 ENGINEERED MUTATION            
SEQADV 3KZ3 TYR B   32  UNP  P03034    GLN    34 ENGINEERED MUTATION            
SEQADV 3KZ3 ALA B   45  UNP  P03034    GLY    47 ENGINEERED MUTATION            
SEQADV 3KZ3 ALA B   47  UNP  P03034    GLY    49 ENGINEERED MUTATION            
SEQADV 3KZ3 ARG B   84  UNP  P03034              SEE REMARK 999                 
SEQRES   1 A   80  SER LEU THR GLN GLU GLN LEU GLU ASP ALA ARG ARG LEU          
SEQRES   2 A   80  LYS ALA ILE TRP GLU LYS LYS LYS ASN GLU LEU GLY LEU          
SEQRES   3 A   80  SER TYR GLU SER VAL ALA ASP LYS MET GLY MET GLY GLN          
SEQRES   4 A   80  SER ALA VAL ALA ALA LEU PHE ASN GLY ILE ASN ALA LEU          
SEQRES   5 A   80  ASN ALA TYR ASN ALA ALA LEU LEU ALA LYS ILE LEU LYS          
SEQRES   6 A   80  VAL SER VAL GLU GLU PHE SER PRO SER ILE ALA ARG GLU          
SEQRES   7 A   80  ILE ARG                                                      
SEQRES   1 B   80  SER LEU THR GLN GLU GLN LEU GLU ASP ALA ARG ARG LEU          
SEQRES   2 B   80  LYS ALA ILE TRP GLU LYS LYS LYS ASN GLU LEU GLY LEU          
SEQRES   3 B   80  SER TYR GLU SER VAL ALA ASP LYS MET GLY MET GLY GLN          
SEQRES   4 B   80  SER ALA VAL ALA ALA LEU PHE ASN GLY ILE ASN ALA LEU          
SEQRES   5 B   80  ASN ALA TYR ASN ALA ALA LEU LEU ALA LYS ILE LEU LYS          
SEQRES   6 B   80  VAL SER VAL GLU GLU PHE SER PRO SER ILE ALA ARG GLU          
SEQRES   7 B   80  ILE ARG                                                      
FORMUL   3  HOH   *282(H2 O)                                                    
HELIX    1   1 THR A    7  GLY A   29  1                                  23    
HELIX    2   2 SER A   31  MET A   39  1                                   9    
HELIX    3   3 GLY A   42  ASN A   51  1                                  10    
HELIX    4   4 ASN A   57  LYS A   69  1                                  13    
HELIX    5   5 SER A   71  PHE A   75  5                                   5    
HELIX    6   6 SER A   76  ARG A   84  1                                   9    
HELIX    7   7 THR B    7  GLY B   29  1                                  23    
HELIX    8   8 SER B   31  GLY B   40  1                                  10    
HELIX    9   9 GLY B   42  ASN B   51  1                                  10    
HELIX   10  10 ASN B   57  LYS B   69  1                                  13    
HELIX   11  11 SER B   71  PHE B   75  5                                   5    
HELIX   12  12 SER B   76  ARG B   84  1                                   9    
CRYST1   32.630   58.710   42.850  90.00  98.18  90.00 P 1 21 1      4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.030647  0.000000  0.004405        0.00000                         
SCALE2      0.000000  0.017033  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.023577        0.00000                         
ATOM      2  CA  SER A   5      28.046   3.314  -8.237  1.00 24.76           C  
ATOM      8  CA  LEU A   6      25.367   0.683  -7.574  1.00 16.75           C  
ATOM     16  CA  THR A   7      25.242  -2.643  -9.406  1.00 15.20           C  
ATOM     23  CA  GLN A   8      22.078  -3.653 -11.257  1.00 14.97           C  
ATOM     32  CA  GLU A   9      21.066  -5.891  -8.349  1.00 21.00           C  
ATOM     41  CA  GLN A  10      21.600  -3.037  -5.889  1.00 14.22           C  
ATOM     50  CA  LEU A  11      19.425  -0.844  -8.107  1.00 13.73           C  
ATOM     58  CA  GLU A  12      16.715  -3.501  -8.144  1.00 14.32           C  
ATOM     67  CA  ASP A  13      16.840  -3.765  -4.352  1.00 15.98           C  
ATOM     75  CA  ALA A  14      16.237  -0.039  -4.161  1.00 13.60           C  
ATOM     80  CA  ARG A  15      13.468  -0.162  -6.734  1.00 13.11           C  
ATOM     91  CA  ARG A  16      11.678  -2.962  -4.905  1.00 16.21           C  
ATOM    102  CA  LEU A  17      12.128  -1.112  -1.626  1.00 12.55           C  
ATOM    110  CA  LYS A  18      10.699   2.109  -3.075  1.00 16.73           C  
ATOM    119  CA  ALA A  19       7.689   0.200  -4.391  1.00 17.40           C  
ATOM    124  CA  ILE A  20       6.919  -1.148  -0.939  1.00 13.35           C  
ATOM    132  CA  TRP A  21       7.356   2.353   0.569  1.00 17.46           C  
ATOM    146  CA  GLU A  22       4.864   3.807  -1.885  1.00 13.62           C  
ATOM    155  CA  LYS A  23       2.444   0.950  -1.157  1.00 16.41           C  
ATOM    164  CA  LYS A  24       2.634   0.963   2.669  1.00 16.21           C  
ATOM    173  CA  LYS A  25       3.724   4.409   3.880  1.00 13.09           C  
ATOM    182  CA  ASN A  26       0.267   5.877   4.378  1.00 16.78           C  
ATOM    190  CA  GLU A  27      -1.349   2.910   6.092  1.00 16.47           C  
ATOM    199  CA  LEU A  28       1.615   2.537   8.396  1.00 15.66           C  
ATOM    207  CA  GLY A  29       1.741   6.247   9.198  1.00 16.24           C  
ATOM    211  CA  LEU A  30       5.289   6.734   7.899  1.00 13.46           C  
ATOM    219  CA  SER A  31       7.031   9.951   6.894  1.00 17.02           C  
ATOM    225  CA  TYR A  32      10.546  10.570   5.697  1.00 15.71           C  
ATOM    237  CA  GLU A  33      11.132  12.379   8.977  1.00 18.72           C  
ATOM    246  CA  SER A  34       9.874   9.607  11.230  1.00 15.13           C  
ATOM    252  CA  VAL A  35      11.860   7.002   9.303  1.00 16.30           C  
ATOM    259  CA  ALA A  36      14.946   9.147   9.308  1.00 19.90           C  
ATOM    264  CA  ASP A  37      14.658   9.496  13.074  1.00 16.32           C  
ATOM    272  CA  LYS A  38      14.342   5.748  13.587  1.00 17.77           C  
ATOM    281  CA  MET A  39      17.326   5.164  11.293  1.00 14.22           C  
ATOM    289  CA  GLY A  40      19.562   7.700  12.990  1.00 14.13           C  
ATOM    293  CA  MET A  41      20.064   9.538   9.672  1.00 17.29           C  
ATOM    301  CA  GLY A  42      18.729  12.540   7.722  1.00 18.60           C  
ATOM    305  CA  GLN A  43      15.765  12.596   5.381  1.00 11.57           C  
ATOM    314  CA  SER A  44      17.944  12.893   2.284  1.00 13.44           C  
ATOM    320  CA  ALA A  45      19.894   9.764   3.263  1.00 14.66           C  
ATOM    325  CA  VAL A  46      16.636   7.856   3.568  1.00 12.21           C  
ATOM    332  CA  ALA A  47      15.559   9.055   0.124  1.00 16.29           C  
ATOM    337  CA  ALA A  48      18.986   8.101  -1.238  1.00 12.40           C  
ATOM    342  CA  LEU A  49      18.360   4.494  -0.207  1.00 15.01           C  
ATOM    350  CA  PHE A  50      14.894   4.401  -1.796  1.00 13.35           C  
ATOM    361  CA  ASN A  51      16.111   6.109  -4.963  1.00 18.83           C  
ATOM    369  CA  GLY A  52      19.094   3.800  -5.540  1.00 18.32           C  
ATOM    373  CA  ILE A  53      21.695   6.496  -4.923  1.00 15.85           C  
ATOM    381  CA  ASN A  54      23.336   4.814  -1.931  1.00 18.35           C  
ATOM    389  CA  ALA A  55      23.301   1.024  -1.479  1.00 15.55           C  
ATOM    394  CA  LEU A  56      21.595  -0.874   1.305  1.00 18.67           C  
ATOM    402  CA  ASN A  57      23.445  -2.758   4.014  1.00 16.88           C  
ATOM    410  CA  ALA A  58      22.326  -5.413   6.495  1.00 14.10           C  
ATOM    415  CA  TYR A  59      21.494  -3.021   9.338  1.00 14.81           C  
ATOM    427  CA  ASN A  60      19.466  -0.570   7.243  1.00 15.64           C  
ATOM    435  CA  ALA A  61      17.717  -3.330   5.339  1.00 13.64           C  
ATOM    440  CA  ALA A  62      16.678  -5.097   8.536  1.00 14.28           C  
ATOM    445  CA  LEU A  63      15.411  -1.890  10.129  1.00 15.92           C  
ATOM    453  CA  LEU A  64      13.500  -0.803   7.021  1.00 12.79           C  
ATOM    461  CA  ALA A  65      11.932  -4.224   6.786  1.00 15.99           C  
ATOM    466  CA  LYS A  66      10.764  -3.885  10.417  1.00 19.11           C  
ATOM    475  CA  ILE A  67       9.449  -0.380   9.710  1.00 15.69           C  
ATOM    483  CA  LEU A  68       7.601  -1.463   6.596  1.00 11.92           C  
ATOM    491  CA  LYS A  69       6.433  -4.747   8.167  1.00 14.70           C  
ATOM    500  CA  VAL A  70       7.868  -6.836   5.366  1.00 16.70           C  
ATOM    507  CA  SER A  71      10.543  -9.523   5.173  1.00 18.99           C  
ATOM    513  CA  VAL A  72      13.907  -8.261   3.887  1.00 15.69           C  
ATOM    520  CA  GLU A  73      13.788 -10.628   0.951  1.00 17.35           C  
ATOM    529  CA  GLU A  74      10.746  -8.781  -0.429  1.00 13.67           C  
ATOM    538  CA  PHE A  75      13.209  -6.080  -1.523  1.00 14.29           C  
ATOM    549  CA  SER A  76      16.735  -7.579  -1.140  1.00 18.55           C  
ATOM    555  CA  PRO A  77      17.014 -11.372  -1.510  1.00 17.00           C  
ATOM    562  CA  SER A  78      20.806 -11.038  -1.398  1.00 15.52           C  
ATOM    568  CA  ILE A  79      20.936  -9.057   1.828  1.00 17.46           C  
ATOM    576  CA  ALA A  80      18.324 -11.336   3.402  1.00 18.22           C  
ATOM    581  CA  ARG A  81      20.794 -14.166   2.944  1.00 16.61           C  
ATOM    592  CA  GLU A  82      23.539 -12.083   4.614  1.00 27.77           C  
ATOM    601  CA  ILE A  83      21.358 -11.584   7.676  1.00 21.61           C  
ATOM    609  CA  ARG A  84      20.721 -15.333   7.725  1.00 68.03           C  
TER     619      ARG A  84                                                      
MASTER      219    0    0   12    0    0    0    6 1518    2    0   14          
END                                                                             
